The distinct roles of sialyltransferases in cancer biology and onco-immunology
M Hugonnet, P Singh, Q Haas… - Frontiers in …, 2021 - frontiersin.org
Aberrant glycosylation is a key feature of malignant transformation. Hypersialylation, the
enhanced expression of sialic acid-terminated glycoconjugates on the cell surface, has …
enhanced expression of sialic acid-terminated glycoconjugates on the cell surface, has …
Aberrant sialylation in cancer: biomarker and potential target for therapeutic intervention?
S Pietrobono, B Stecca - Cancers, 2021 - mdpi.com
Simple Summary Sialylation is a post-translational modification that consists in the addition
of sialic acid to growing glycan chains on glycoproteins and glycolipids. Aberrant sialylation …
of sialic acid to growing glycan chains on glycoproteins and glycolipids. Aberrant sialylation …
LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis
X Bi, XH Guo, BY Mo, ML Wang, XQ Luo, YX Chen… - …, 2019 - thelancet.com
Abstract Background Long non-coding RNAs (lncRNAs) have drawn increasing attention
because they play a pivotal role in various types of autoimmune diseases, including …
because they play a pivotal role in various types of autoimmune diseases, including …
Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
X Wu, J Zhao, Y Ruan, L Sun, C Xu, H Jiang - Cell death & disease, 2018 - nature.com
Sialyltransferases transfer sialic acid to nascent oligosaccharides and are upregulated in
cancer. The inhibition of sialyltransferases is emerging as a potential strategy to prevent …
cancer. The inhibition of sialyltransferases is emerging as a potential strategy to prevent …
Resistance to cisplatin in human lung adenocarcinoma cells: Effects on the glycophenotype and epithelial to mesenchymal transition markers
LM da Fonseca, VA da Silva, KM da Costa… - Glycoconjugate …, 2022 - Springer
The characteristics that grant the most malignancy to cancer cells are the ability to evade
apoptotic mechanisms and the capacity to migrate beyond the boundaries of the original …
apoptotic mechanisms and the capacity to migrate beyond the boundaries of the original …
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways
Like almost all cancer types, timely diagnosis is needed for leukemias to be effectively
cured. Drug efflux, attenuated drug uptake, altered drug metabolism, and epigenetic …
cured. Drug efflux, attenuated drug uptake, altered drug metabolism, and epigenetic …
Epigenetic bases of aberrant glycosylation in cancer
F Dall'Olio, M Trinchera - International journal of molecular sciences, 2017 - mdpi.com
In this review, the sugar portions of glycoproteins, glycolipids, and glycosaminoglycans
constitute the glycome, and the genes involved in their biosynthesis, degradation, transport …
constitute the glycome, and the genes involved in their biosynthesis, degradation, transport …
The expression and functional analysis of the sialyl-T antigen in prostate cancer
R Bai, X Luan, Y Zhang, C Robbe-Masselot… - Glycoconjugate …, 2020 - Springer
Aberrant glycosylation is a featured characteristic of cancer and plays a role in cancer
pathology; thus an understanding of the compositions and functions of glycans is critical for …
pathology; thus an understanding of the compositions and functions of glycans is critical for …
Sialyltransferases and neuraminidases: potential targets for cancer treatment
Cancers are the leading cause of death, causing around 10 million deaths annually by
2020. The most common cancers are those affecting the breast, lungs, colon, and rectum …
2020. The most common cancers are those affecting the breast, lungs, colon, and rectum …
The lncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation
A Gong, X Zhao, Y Pan, Y Qi, S Li… - Journal of cell …, 2020 - journals.biologists.com
Long noncoding RNAs (lncRNAs) have emerged as important regulators of cancer
progression. Abnormal sialylation leads to renal cell carcinoma (RCC) malignancy …
progression. Abnormal sialylation leads to renal cell carcinoma (RCC) malignancy …